Genexis Biotech: Financial Breakdown
Decoding financial health metrics of Genexis Biotech
Total Revenue₹15.4 Lakh-54%Prev. FY
Total Expenses₹1.2 Cr95%Prev. FY
Profit After Tax₹-99.6 Lakh-293%Prev. FY
Total Assets₹1.5 Cr28%Prev. FY
Net Profit Margin-648.8%-741%Prev. FY
FAQs on Financials of Genexis Biotech
No. In FY25, Genexis Biotech reported a net loss of ₹99.6 Lakh, so it was not profitable.
Genexis Biotech's revenue declined 53.3% year-on-year, from ₹32.9 Lakh in FY24 to ₹15.4 Lakh in FY25.
Genexis Biotech's estimated EBITDA for FY25 was ₹-77.9 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Genexis Biotech posted revenue of ₹15.4 Lakh (down 53.3% YoY) and a net loss of ₹99.6 Lakh. Explore the full financials of Genexis Biotech here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links